New myosin inhibitors reshape treatment of obstructive hypertrophic cardiomyopathy
A new review maps how mavacamten and aficamten are reshaping the treatment pathway for hypertrophic obstructive cardiomyopathy, from first-line drugs ...
A new review maps how mavacamten and aficamten are reshaping the treatment pathway for hypertrophic obstructive cardiomyopathy, from first-line drugs ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine